| abstract |
The present invention relates to a docetaxel albumin nanoparticle pharmaceutical composition, a preparation method therefor, and a use thereof for manufacturing drugs for treating cancer. The pharmaceutical composition comprises docetaxel, albumin and amino acid(s), wherein the weight ratio of albumin to docetaxel is no more than 50, preferably is from 20:1 to 1:1, and the weight ratio of the amino acid(s) to docetaxel is no less than 0.5, preferably is from 1:1 to 20:1. |